MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.

scientific article published in July 1990

MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2141.1990.TB04346.X
P698PubMed publication ID1696833

P50authorRichard A. LarsonQ41899936
P2093author name stringSato H
Goldberg J
Gottlieb A
Day R
Raza A
Preisler H
Browman G
Grunwald H
Vogler R
P2860cites workAmplification of DNA sequences in human multidrug-resistant KB carcinoma cellsQ37555261
Failure of remission induction in acute myelocytic leukemiaQ40547433
Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesQ42812351
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell linesQ42818012
Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver.Q54406581
The mdrl gene, responsible for multidrug-resistance, codes for P-glycoproteinQ58449756
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
P304page(s)340-345
P577publication date1990-07-01
P1433published inBritish Journal of HaematologyQ4970200
P1476titleMDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.
P478volume75